Value of ablation therapy in the treatment of lung metastases

E-ISSN： 1759-7714|9|2|199-207

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.9, Iss.2, 2018-02, pp. : 199-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment and prognostic analysis of patients with leptomeningeal metastases from non‐small cell lung cancer

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 407-412

John Wiley & Sons Inc

Access to resources Recommend Favorite

Radiofrequency ablation (RFA) for palliative treatment of painful non‐small cell lung cancer (NSCLC) rib metastasis: Experience in 12 patients

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 761-764

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival predictors after resection of lung metastases of head or neck cancers

Thoracic Cancer, Vol. 6, Iss. 5, 2015-09 ,pp. : 579-583

John Wiley & Sons Inc

Access to resources Recommend Favorite

Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non‐small cell lung cancer

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 327-333

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current small cell lung cancer treatment in China

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 233-238

John Wiley & Sons Inc

Access to resources Recommend Favorite